- Asthma - Emerging Therapies - Asthma & COPD | Salmeterol & Fluticasone Generic Wave 2 (US)
- Asthma and COPD Emerging Therapies Salmeterol / Fluticasone Generic US Wave 2 (October 2019)
Author(s): Ajay Puri, M.B.A.
Ajay Puri, M.B.A., is an analyst on the Immune and Inflammatory Disorders team at Clarivate. He has developed expertise in ulcerative colitis, Crohn’s disease, and systemic lupus erythematosus. Previously, he worked as a knowledge management associate at ZS Associates, where he conducted competitive assessment, company and product profiling, and other projects. He holds a bachelor’s degree in pharmacy and an M.B.A. in marketing from the National Institute of Pharmaceutical Education and Research in Mohali, India.